The global Digital Respiratory Devices Market was valued at $72.69 billion in 2024 and is projected to reach $514.74 billion by 2032, with a CAGR of 27.77% fueled by increasing chronic respiratory diseases, sensor-enabled inhalers, AI integration, and home-based care. The U.S. market is expected to grow from $25.90 billion in 2024 to $156.79 billion by 2032 at a CAGR of 25.27%. Strong investments and adoption of digital respiratory care are driving growth globally.

In 2024, smart inhalers and nebulizers accounted for the largest market share in the digital respiratory device market, while COPD held the largest disease indication share. Hospital pharmacies led distribution channels, and hospitals held the largest end-use share. North America dominated the market in 2024, with Asia Pacific showing the fastest growth at a 28.74% CAGR.

Recent developments include Medtronic’s Touch Surgery Live Stream platform and ResMed’s patient-focused innovations. SNS Insider offers customization research on the Digital Respiratory Devices Market, focusing on disease burden, smart inhaler adoption, remote monitoring, reimbursement landscape, and patient engagement insights. Related reports include Smart Inhalers, Remote Patient Monitoring, Respiratory Care Devices, and Home Healthcare Devices.

SNS Insider is a leading market research and consulting agency providing clients with current, accurate market data and insights to make confident decisions in changing circumstances. Techniques include surveys, video talks, and focus groups globally.

Read more at GlobeNewswire: Digital Respiratory Devices Market Size to Reach $514.74